-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.P1.67 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I

Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Jule Ussmann, MD1*, Clara Wall1*, Lara Bischof, MD1*, Jacob Jendro1*, Dominic Brauer, MD1*, Donata Backhaus, MD1*, Klaus H Metzeler, MD1, Marco Herling, MD1*, Carmen Herling, MD1*, Vladan Vucinic, MD1*, Georg-Nikolaus Franke, MD1*, Maximilian Merz, MD1, Timm Denecke, MD2*, Uwe Platzbecker, MD1, Sebastian Schwind, MD1*, Hans-Jonas Meyer, MD2* and Madlen Jentzsch, MD1*

1Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
2Department for Diagnostic and Interventional Radiology, University of Leipzig Medical Center, Leipzig, Germany

Lidan Zhu1,2*, Jia Liu2*, Huanfeng Liu2*, Shichun Gao2*, Lu Wang2*, Peiyan Kong2*, Xi Zhang, PhD3,4 and Lei Gao, MD, PhD5,6*

1Army medical University affiliated Xinqiao Hospital, Chongqing, China
2Army Medical University, Chongqing, China
3Affiliated xinqiao Hospital of Army medical University,chongqing ,China, chongqing city, China
4Jinfeng Laboratory, Chongqing, China
5Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
6Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China

Rui MA1,2*, Xueyi Luo2,3*, Wei Sun2,3*, Wei Han2,3*, Yun He, PhD2,3*, Yu Wang2,3*, Xiaohui Zhang, MD2,4, Lanping Xu, MD2,3*, Kaiyan Liu2,3, Xiao Jun Huang, MD2,3 and Yuqian Sun2,3*

1Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
2National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
4Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China

Jan Vydra, MD, PhD1*, Allain-Thibeault Ferhat2*, Nicolaus Kröger, MD3*, Tobias Gedde-Dahl4*, Matthias Eder, MD5*, Thomas Schroeder6*, Urpu Salmenniemi, MD7*, Gerard Socie8, Jakob Passweg Sr.9, Ibrahim Yakoub-Agha, MD, PhD10*, Alessandro Rambaldi11, Robert Zeiser, MD12, Matthias Stelljes, MD13*, Kristina Carlson14, Cristina Castilla-Llorente, MD15*, Alexandros Spyridonidis, MD, PhD16*, Fabio Ciceri, MD17* and Mohamad Mohty, MD, PhD18

1Institute of Haematology and Blood Transfusion, Prague, Czech Republic
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3University Medical Center Hamburg, Hamburg, Germany
4Rikshospitalet, Oslo University Hospital, Oslo, Norway
5Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
6Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Essen, Germany
7HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
8Hematology Transplantation, Paris, France
9University Hospital Basel, Basel, Switzerland
10CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
11Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
12Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
13Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
14Uppsala University, Uppsala, Uppsala Laen, SWE
15Gustave Roussy Cancer Campus, Villejuif, France
16Department of Internal Medicine, Bone Marrow Transplantation Unit, University Hospital of Patras, Patras, Greece
17Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
18Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France

Michikata Hayashida1*, Aya Nishida, MD2*, Mika Kuno, MD2*, Otoya Watanabe, MD2*, Daisuke Kaji, MD, PhD2*, Yuki Taya, MD, PhD2*, Shinsuke Takagi, MD, PhD2*, Hisashi Yamamoto, MD, PhD2*, Go Yamamoto, MD, PhD2*, Suguru Oka1*, Kazushige Sakaguchi1*, Shinji Urakami1* and Naoyuki Uchida3

1Department of Urology, Toranomon Hospital, Tokyo, Japan
2Department of Hematology, Toranomon Hospital, Tokyo, Japan
3Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan

Hermioni L Amonoo, MD1,2,3, Emma D Wolfe, BA1*, Emma P Keane, BA4*, Isabella S Larizza, BS4*, Richard Newcomb, MD5* and Areej El-Jawahri, MD5,6

1Brigham and Women's Hospital, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Harvard Medical School, Boston, MA
4Brigham and Women’s Hospital, Boston
5Massachusetts General Hospital, Boston, MA
6Massachusetts General Hospital, Allston, MA

Yanzhi Song1*, Erhui Yuan2*, Qishu Qin2*, Qi Wang2,3*, Zhanxiang Liu4*, Kong Gao4*, Zhihui Li1*, Yongqiang Zhao1* and Tong Wu, MD1

1Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China
2Department of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing, China
3Department of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing, Beijing, China
4Beijing Gaobo Boren Hospital, Beijing, China

Daniel Stapor1, Yuliya Shestovska, MD2*, Michael Styler, MD3, Peter Abdelmessieh, MD4, Rashmi Khanal, MD5, Henry C. Fung, FRCP, MBBChir5, Anne Ojala2* and Asya Varshavsky Yanovsky, MD, PhD6

1Temple University Health System, Fox Chase Cancer Center, Philadelphia, PA
2FOX-CHASE, Philadelphia, PA
3Bone Marrow Transplant and Cellular Therapies, Fox Chase Cancer Center, Philadelphia, PA
4FOX-CHASE Cancer Center, Glen Mills, PA
5Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA
6Fox Chase Cancer Center, Philadelphia, PA

Kimimori Kamijo1*, Yoshimitsu Shimomura, MD, PhD2,3*, Naoyuki Uchida4, Satoshi Yoshihara, MD, PhD5, Takahiro Fukuda6*, Yasufumi Uehara, MD, PhD7*, Yasuo Mori, M.D., Ph.D.8*, Tetsuya Eto9*, Hikaru Kobayashi10*, Kentaro Serizawa, MD11*, Tatsuo Ichinohe, MD, PhD12*, Makoto Yoshimitsu, MD, PhD13, Junya Kanda, MD, PhD14*, Yoshiko Atsuta, MD, PhD15* and Shinichi Kako, MD, PhD16

1Department of Hematology, Rinku General Medical Center, Izumisanoshi, HYO, Japan
2Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
3Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan
4Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan
5Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan
6Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
7Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
8Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
9Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
10Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan
11Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Hospital, Osakasayama, JPN
12Department of Hematology and Oncology, Research Institute For Radiation Biology and Medicine, Hiroshima University, Hiroshima, JPN
13Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University Hospital, Kagoshima, Japan
14Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
15Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
16Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan

Mohamed Ali, MD, PhD1*, Emily Limerick, MD1, Matthew Hsieh, MD1, Kalpana Upadhyaya, PhD2*, Xin Xu, MD, PhD1*, Oswald Phang, BSChE1*, Jean Pierre Kambala Mukendi, MD, PhD1, Katherine R. Calvo, MD, PhD2, Maria Lopez-Ocasio, PhD3*, Pradeep Dagur, PhD4* and Courtney Fitzhugh, MD5

1Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD
2Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD
3Flow Cytometry Core, National Heart, Lung and Blood Institute, NIH, Bethesda, MD
4Flow Cytometry Core, National Heart Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD
5National Institutes of Health, Bethesda, MD

Giulia Losi, MD1,2*, Annamaria Pasi3*, Carmen Tania Prezioso3*, Bianchessi Antonio1,2*, Caterina Zerbi2*, Irene Defrancesco2,4*, Anna Amelia Colombo2*, Francesco Romano1,2*, Valentina Da Prat5*, Alessia Taurino2*, Valentina Zoboli2*, Luca Arcaini1,2*, Cesare Perotti6*, Riccardo Caccialanza5* and Nicola Polverelli2

1Department of Molecular Medicine, University of Pavia, Pavia, Italy
2Unit of Bone Marrow Transplantation - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
3Immunohematology and Transfusion Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Deparment of Surgical, Clinical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
5Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
6Immunohematology and Transfusion Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy

Ahsan Wahab, MD1, Karen Sweiss, PharmD2, Noah Birch, MD, PhD3* and Matias Sanchez, MD2

1University of Illinois at Chicago, Chicago, IL
2Division of Hematology/Oncology, University of Illinois Cancer Center, Chicago, IL
3Division of Hematology & Oncology, University of Illinois Chicago, Chicago, IL

Catherine J. Lee, MD, MSc1, Elizabeth M Hellewell, BS1*, Kevin Ng, M.S.1*, Ted Gooley, PhD2*, Anthony D. Sung, MD3, Allison O. Taylor, MD, MS4*, Sanghee Hong, MD5*, Nausheen Ahmed, MD6*, Cherie Morey, MD7*, Sarah Fitzmaurice7*, Vanessa E. Kennedy, MD8, Michelle Lauer9*, Andrew D. Trunk, MD10, Betty K. Hamilton, MD11, Akshay Sharma, MBBS12, Zoey Phelps-Bergeron12*, LaQuisa Hill, MD13*, Rawan Faramand, MD14, Hien Liu, MD15, Lena E Winestone, MD16, Geoffrey Cheng16, Manuel Espinoza-Gutarra, MD17, Omer Jamy, MD18, Maria Odstrcil Bobillo, MD19*, Brian McClune, DO19, Mariam T. Nawas, MD20, Samuel J. Yates, MD, MSc21, Miki Nishitani, MD, BS22, Takuto Takahashi, MD, PhD22*, Jane Koo, MD23*, Kasiani C Myers, MD24, Kris Michael Mahadeo, MD25, Andrea Bauchat, DO26*, Laurie K Pearson, MD27, Ritika Walia, MD28*, Kelsea Seago, PharmD, RPh29*, Spencer Yingling, PharmD30*, Cory Edgar, PA-C31*, Amy Browning, APRN31* and Neel Bhatt, MBBS1*

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC
4Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC
5Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
6Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
7Division of hematologic malignancies and cellular therapeutics, University of Kansas Cancer Center, Westwood, KS
8Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
9Stanford University, Stanford, CA
10Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Shaker Heights, OH
11Cleveland Clinic Foundation, Cleveland, OH
12Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
13Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Methodist Hospital, Houston, TX
14Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
15Moffitt Cancer Center, Tampa, FL
16Division of Allergy, Immunology, & BMT, Department of Pediatrics, UCSF Benioff Children's Hospitals, San Francisco, CA
17O'Neal Comprehensive Cancer Center at University of Alabama Birmingham, Birmingham, AL
18O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
19Huntsman Cancer Institute, University of Utah, Division of Hematology and Hematologic Malignancies, Salt Lake City, UT
20Department of Medicine, Section of Hematology/Oncology, University of Chicago, Oak Park, IL
21Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
22Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
23Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
24Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
25Pediatric Transplant and Cellular Therapy, Duke University, Durham, NC
26Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC
27UMass Memorial Medical Center, Department of Medicine, Waltham, MA
28UMass Memorial Medical Center, Department of Medicine, Worcester, MA
29West Virginia University Medicine, Morgantown, WV
30West Virginia University Medicine, Morgantown
31AdventHealth, Orlando, FL

Lizhen Liu1*, Shipei Xiang1*, Xiaoyu Lai, MD1*, Jimin Shi1*, Yanmin Zhao, MD1*, Jian Yu, MD1*, Ying Lu2*, Peipei Ye2*, Guifang Ouyang3*, Baodong Ye4*, Jianping Lan5*, Pengfei Shi6*, Haowen Xiao7*, Huarui Fu, MD8*, Luxin Yang, MD1*, Yishan Ye, MD1*, Yi Chen9*, Yu Zhang10*, Yang Xu11*, Huixian Hu12*, Huifang Jiang13*, Yamin Tan14*, He Huang, MD1* and Yi Luo1

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
3Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
4The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
5Department of Hematology, Zhejiang Provincial People’s Hospital, Hangzhou, China
6Hangzhou First People's Hospital, Hangzhou, China
7Institute of Hematology, Zhejiang University, Hangzhou, China
8Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
9Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
10Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China, Wenzhou, China
11the Department of Hematology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
12Department of Hematology, Jinhua Central Hospital, Jinhua, China
13Department of Hematology, Tongde Hospital of Zhejiang Province, Hangzhou, China
14Zhejiang Cancer Hospital, Hangzhou, China

Moazzam Shahzad, MD1,2, Muhammad Kashif Amin, MD2,3,4*, Ben Ponvilawan, MD2,3*, Hana Qasim2*, Matthew McGuirk2,3*, Sibgha Gull Chaudhary, MD3,4*, Iqra Anwar, MBBS2,3*, Abat Khan, MD2,3*, Abdulraheem Yacoub, MD2,5*, Anurag K. Singh, MD2,3,4, Mehdi Hamadani, MD6, Joseph P. McGuirk, DO2,3,4 and Muhammad Umair Mushtaq3,4,7

1Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
2Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
5University of Kansas Medical Center, Westwood, KS
6Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
7MRF, Kansas City

Mazin Mohamed Abdulsalam, MD1,2,3*, Bader Alahmari, MD1,2,3,4*, Ahmed Alaskar, MD1,2,3,4, Ayman Alhejazi, MD1,2,3,4*, Abdullah AlSaleh, MD2,3,4*, Husam Mazin Alsadi, MD2,3*, Mohammed Bakkar, MD2,3*, Abdulrahman Al Raizah, MD2,4,5, Hind Salama, MD2,3,4*, Ayman Ibrahim, MD2,3*, Ayel Yahya, MD2,3*, Sumaya Altamimi, MBBS3*, Khalid Aldosari, MD3*, Abdul Rauf Ghori, MD2,3*, Afnan Alnajjar, MD3*, Khalid Alharbi, MD3*, Nahla Wahby, MD3*, Mohammed Ali, MD3*, Inaam Shehabeddine3*, Rasha Ahmed3*, Tahani Alanazi3*, Isam Mahasneh3*, Suha Alkhraisat3*, Hamza Alquraan3*, Amani Alharbi3*, Afnan Alzaidi3*, Eman Anizi3*, Norah Alshuraym, PharmD3*, Maybelle Ballili3* and Mohsen Alzahrani, MBChB1,2,3,4

1Saudi Scientific Society of Blood and Marrow Transplantation (SSBMT), Riyadh, Saudi Arabia
2King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
3King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
4College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
5King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Sarasota, FL

Yue Shang1,2*, Yuanyuan Ren2,3*, Lipeng Liu2,4*, Xin Wang1,2*, Chaoqian Jiang1,2*, Xia Chen1,2*, Yang Wan, MD PhD4*, Aoli Zhang1,2*, Xiaoyan Zhang1,2*, Fang Liu, MD1,2*, Li Zhang1,2*, Yumei Chen1,2*, Yao Zou1,2*, Xiaojuan Chen, MD2,4*, Wenyu Yang1,2*, Xiaofan Zhu, MD2,5 and Ye Guo2,4*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, AL, China
4Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

Devin McAvoy1*, Matthew Thomsen, MPH2*, Evangelos Ntrivalas, MD, PhD3*, Elizabeth Klein, MPH4*, Kinga K. Hosszu, PhD1*, Jaap Jan Boelens, MD5 and Joseph H. Oved, MD6

1Department of Pediatrics, Immune Discovery and Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York
4Pediatric Transplantation and Cellular Therapies Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
5Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
6Transplantation and Cellular Therapy, Memorial Sloan Kettering Cancer Center (MSK Kids), New York, NY

Allison Gradone, MD1*, Xia Bi, MD2*, Satya Durugu, MD1*, Boula Gattas, MD3*, Alicia Bao, MD4*, ArponaDev Nath, MD5*, Joanne Filicko-O'Hara, MD2, Brenda Grande1*, Gina Mateja1*, William O'Hara, PharmD1*, John Wagner, MD1*, Dolores Grosso, DNP1*, Neal Flomenberg, MD1* and Usama Gergis, MD, MBA2

1Thomas Jefferson University, Philadelphia
2Department of Bone Marrow Transplant and Cellular Therapy, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
3Thomas Jefferson University, Fairless Hills, PA
4Thomas Jefferson University, Philadelphia, PA
5Thomas Jefferson University Hospital, Philadelphia, PA

Julian Ronnacker, MD1*, Marc-Andre Urbahn, MD1*, Christian Reicherts, MD1*, Lina Kolloch, MD1*, Philipp Berning2*, Simon Call2*, Matthias Floeth, MD1*, Julia Marx, MD1*, Jan-Henrik Mikesch, MD2*, Christoph Schliemann, MD3*, Georg Lenz2 and Matthias Stelljes, MD4

1Department of Medicine A (Hematology, Hemostaseology, Oncology, Pneumology), University Hospital Muenster, Muenster, Germany
2Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
3Department of Medicine A, University Hospital Muenster, Muenster, Germany
4Department of Medicine A (Hematology, Hemostaseology, Oncology, Pneumology), University of Muenster, Muenster, Germany

*signifies non-member of ASH